RAPP

NASD Rapport Therapeutics, Inc.

Oct 31, 2026 · 4:00 AM ET EOD Market Closed

$25.05 ↑ +0.00 (+0.00%) Trading Up from the previous close of $25.05, $0.38 below the day’s high of $25.43

YTD change: -17.44%
vs 20-day SMA: -11.57%
vs 200-day SMA: -29.75%

Price ranges

Previous day

$23.86 $25.43

open $23.94 close $25.05

+$1.11 (+4.64%)

Today

$23.86 $25.43

$25.05

Past week

$22.06 $28.31

from $26.53 now $25.05

-$1.48 (-5.58%)

Past month

$22.06 $34.48

from $32.83 now $25.05

-$7.78 (-23.70%)

This year

$22.06 $52.93

from $30.34 now $25.05

-$5.29 (-17.44%)

Price & Performance

-8.84 (-26.08%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral

The stock is 52.7% away from all-time highs of $52.93
RAPP is down 17% since the beginning of the year
RAPP is down 7% over the past 12 months
RAPP is down 24% over the past 1 month
11% of all RAPP investors are betting against RAPP

RAPP reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is -13.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-1.19

Earnings momentum +1.1% Quarterly EPS growth

Quarterly change +1.1%

Valuation

P/E ratio N/A

Enterprise value $723.2M

Beta 1.22

Balance sheet & scale

IncomeN/A

Revenue$20.0M

Cash$436.2M

Debt$10.1K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $1.2B

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Competitor comparison

Ticker	Company	Price	Change
CSLLY	CSL Limited Sponsored ADR	$35.39	+1.11%
ARGX	argenx SE Sponsored ADR	$892.87	-0.55%
ONC	BeOne Medicines Ltd. Sponsored ADR	$370.33	-0.33%
INCY	Incyte Corporation	$120.39	+3.07%
WXIBF	Wuxi Biologics (Cayman) Inc.	$5.69	-3.64%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.